Canopy Growth Corporation (TSX:WEED)
Canada · Delayed Price · Currency is CAD | Market Cap | 557.24M +88.6% |
| Revenue (ttm) | 293.63M +6.8% |
| Net Income | -232.63M |
| EPS | -0.65 |
| Shares Out | 422.15M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 524,835 |
| Open | 1.330 |
| Previous Close | 1.370 |
| Day's Range | 1.320 - 1.400 |
| 52-Week Range | 1.180 - 3.280 |
| Beta | 2.41 |
| Analysts | Hold |
| Price Target | 2.02 (+53.03%) |
| Earnings Date | Aug 7, 2026 |
About Canopy Growth
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally. The company operates through two segments, Cannabis and Storz & Bickel. It also provides vaporizers and accessories; dried flower and pre-rolled joints, oil, and vapes and beverages; extracts and concentrates, such as softgel capsules; and cannabis edibles, including gummies. In addition, the company operates e-... [Read more]
Full Company ProfileFinancial Performance
In fiscal year 2026, Canopy Growth's revenue was 284.60 million, an increase of 5.80% compared to the previous year's 269.00 million. Losses were -262.91 million, -48.34% less than in 2025.
Financial StatementsAnalyst Summary
According to 8 analysts, the average rating for WEED stock is "Hold." The 12-month stock price target is $2.02, which is an increase of 53.03% from the latest price.
News
Why Rescheduling Might Not Move Canopy Growth's Stock as Much as You Think
The United States is slowly moving toward the legalization of marijuana. The next big step is the rescheduling of the drug at the federal level, which won't make it legal, just less illegal.
Canopy Growth Q1 Earnings Call Highlights
Canopy Growth NASDAQ: CGC reported first-quarter fiscal 2027 net revenue of C$81.2 million, up 13% from the prior-year period, as the company recorded year-over-year growth across its cannabis and Sto...
Canopy Growth Earnings Call Transcript: Q1 2027
Q1 2027 saw 13% revenue growth, margin expansion, and improved EBITDA loss, driven by gains in all business lines and the integration of MTL Cannabis. Management targets further margin improvement, positive adjusted EBITDA, and international growth, especially in Europe.
Canopy Growth Quarterly report: Q1 2027
Canopy Growth has published its Q1 2027 quarterly earnings report on August 7, 2026.
Canopy Growth Earnings release: Q1 2027
Canopy Growth released its Q1 2027 earnings on August 7, 2026, summarizing the period's financial results.
Canopy Growth Earnings release: Q1 2027
Canopy Growth released its Q1 2027 earnings on August 7, 2026, summarizing the period's financial results.
Canopy Growth Registration statement: Q1 2027
Canopy Growth filed a registration statement on August 7, 2026, providing details about a securities offering with the SEC.
Canopy Growth Registration statement: Q1 2027
Canopy Growth filed a registration statement on August 7, 2026, providing details about a securities offering with the SEC.
Canopy Growth Corporation (CGC) Reports Q1 Loss, Tops Revenue Estimates
Canopy Growth (CGC) delivered earnings and revenue surprises of +50.00% and +0.20%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Is Canopy Growth Corp (CGC) Value at Risk After Q1 Earnings Miss? EPS: -$0.09, Revenue: $81. ...
Is Canopy Growth Corp (CGC) Value at Risk After Q1 Earnings Miss? EPS: -$0.09, Revenue: $81.2M, GF Score: 44/100
Canopy Growth Proxy statement: Proxy filing
Canopy Growth filed a proxy statement on August 7, 2026, providing details for shareholder voting and corporate governance matters.
Canopy Growth Proxy statement: Proxy filing
Canopy Growth filed a proxy statement on August 7, 2026, providing details for shareholder voting and corporate governance matters.
Canopy Growth reports Q1 EPS (C$0.03) vs. (C$0.24) last year
Reports revenue C$100.4M vs. C$88.7M last year. “The renewed focus and strong momentum we established over the past year have continued into fiscal 2027. In the first quarter, we achieved…
Canopy Growth Reports First Quarter Fiscal Year 2027 Financial Results; Delivers 13% Net Revenue Growth with Contributions from All Businesses
SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Reports First Quarter Fiscal Year 2027 Financial Results; Delivers 13% Net Revenue Growth with Contributions from All Businesses.
Thinking About Buying Canopy Growth? You May Want to Wait for This 1 Thing to Happen First.
The DEA's decision on rescheduling cannabis is the next key catalyst for Canopy Growth. A decision could be forthcoming following recent government hearings.
Canopy Growth Corporation (CGC) to Release Q1 2027 Financial Results
Canopy Growth Corporation (CGC) to Release Q1 2027 Financial Results
Canopy Growth to Report First Quarter Fiscal 2027 Financial Results on August 7, 2026
SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth to report Q1 2027 financial results on August 7 with a conference call at 10:00am ET.
3 Top Marijuana Stocks to Watch in July 2026
The cannabis industry continues evolving despite ongoing regulatory uncertainty across North America. Investors remain focused on companies with improving financial results and stronger balance sheets...
Canopy Growth Announces Participation at Upcoming Canaccord Genuity Growth Conference
SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) announced it will be participating at the Canaccord Genuity Growth Confer...
Canopy Growth Proxy statement: Proxy filing
Canopy Growth filed a proxy statement on July 17, 2026, providing details for shareholder voting and corporate governance matters.
President Trump's Major Marijuana Move: What It Means for Canopy Growth, Green Thumb, and Tilray
Notably, the move did not affect the vastly larger market for recreational products. It also created new headaches for medical cannabis purveyors.
3 Canadian Marijuana Stocks For Better Investing And Trading 2026
For investors looking to make more green, marijuana stocks may be the way to go. Contrary to the doubt or fear based on the past, the cannabis industry is growing at a fast pace. Now, with cannabis cl...
Is Canopy Growth Stock Finally Worth Buying After Losing 99% of Its Value?
Canopy Growth's turnaround is real, but it remains unfinished. Profitability remains the biggest hurdle for the cannabis producer.
Canopy Growth: Is Another Reverse Stock Split Inevitable?
A reverse stock split may be necessary for Canopy Growth to keep its stock price above $1 and be in compliance with Nasdaq listing requirements. Canopy Growth last did a reverse split in December 2023...
Canopy Growth Slides: Investor presentation
Canopy Growth has posted slides in relation to its latest quarterly earnings report, which was published on July 7, 2026.